Pauline Rudd
Direttore/Membro del Consiglio presso CEVEC Pharmaceuticals GmbH
Provenienza dei contatti di primo grado di Pauline Rudd
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Pauline Rudd tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Cryotherapeutics SA
Cryotherapeutics SA Medical SpecialtiesHealth Technology Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Scienion AG
Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Biotechnology | Chairman Chairman | |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
Peppermint Holding GmbH
Peppermint Holding GmbH TextilesProcess Industries Peppermint Holding GmbH operates as a holding company with interests in textile industries. Its company portfolios include Zwickauer Kammgarn, Ertex Jacquard, and Color Textil. The company was founded by Ingeborg Neumann in 1997 and is headquartered in Berlin, Germany. | Textiles | Chief Investment Officer Corporate Officer/Principal | |
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Investment Managers | Private Equity Investor Private Equity Investor | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Stichting Publieke Private Samenwerking Versterking
Stichting Publieke Private Samenwerking Versterking Investment Trusts/Mutual FundsMiscellaneous Stichting Mibiton promotes research, development, and entrepreneurship in the life sciences sector. The foundation is focused on biomedical sciences, chemistry, food, agricultural, and environmental technology. Stichting Mibiton was founded in 1994, formally called as Stichting Publieke Private Samenwerking Versterking van de Materiële Infrastructuur BioTechnologisch Onderzoek in Nederland and is based in The Hague, The Netherlands. | Investment Trusts/Mutual Funds | Director/Board Member | |
CELLNOVO | Medical Specialties | Director of Finance/CFO | |
Mimetas BV
Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chairman | |
Forbion Co-Investment II Coöperatief UA
Forbion Co-Investment II Coöperatief UA Investment ManagersFinance Part of Forbion Capital Partners Management Holding BV, the venture capital firm, Forbion Co-Investment II Coöperatief UA, is based in Naarden, Netherlands. Forbion Co-Investment II Coöperatief UA operates as a venture capital firm. The Dutch company was founded in 2000 by Bart Bergstein, Hugo Alexander Slootweg, Martien van Osch. | Investment Managers | Founder | |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | Pharmaceuticals: Generic | Director/Board Member | |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Founder | |
TACALYX GmbH
TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services TACALYX GmbH engages in the discovery and development of Tumor Associated Carbohydrate Antigenantibodies to treat cancer. The company was founded by Peter Sondermann, Peter H. Seeberger, and Oren Moscovitz and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
PROSTATYPE GENOMICS AB | Pharmaceuticals: Major | Director/Board Member | |
Duale Hochschule Baden-Württemberg Mannheim | College/University | Undergraduate Degree | |
Kelley School of Business | College/University | Masters Business Admin | |
BIOFRONTERA AG | Pharmaceuticals: Major | Director/Board Member | |
University of Freiburg | College/University | Doctorate Degree | |
Taconic Biosciences GmbH
Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Taconic Biosciences GmbH provides research in genetics and functional genomics. It specializes in the generation of genetic models for biomedical research and testing. The company was founded on October 5, 2001 and is headquartered in Leverkusen, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Technische Universiteit Eindhoven | College/University | Undergraduate Degree | |
Resolve BioSciences GmbH
Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
DIREVO Industrial Biotechnology GmbH
DIREVO Industrial Biotechnology GmbH Miscellaneous Commercial ServicesCommercial Services DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Peppermint VenturePartners GmbH
Peppermint VenturePartners GmbH Investment ManagersFinance Peppermint VenturePartners GmbH (PVP) is an independent venture capital firm founded in 2008 by Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann. It is headquartered in Berlin, Germany. | Investment Managers | Founder | |
Innolume GmbH
Innolume GmbH SemiconductorsElectronic Technology Innolume GmbH manufactures laser diodes. Its products include single mode and broad-are laser diodes, DFB and DBR lasers, superluminescent diodes, semiconductor optical amplifiers, tapered amplifiers, gain chips, laser diode driver, and optical isolators. The company was founded by Bernd Meyer in 2005 and is headquartered in Dortmund, Germany. | Semiconductors | Director/Board Member | |
Peppermint CBF 1 GmbH & Co. KG
Peppermint CBF 1 GmbH & Co. KG Investment ManagersFinance Peppermint CBF 1 GmbH & Co. KG is a venture capital fund that invests in start-up and early-stage companies operating in the healthcare sector. It targets mainly medical devices, diagnostic & services, and biotech companies developing new technology platforms relevant for drug development. The fund invests between €0.5 and €2.5 million per investment round and participates in subsequent rounds with up to €20 million total investment per company. It acquires at least a 10% stake in the target company. | Investment Managers | Corporate Officer/Principal | |
Berlin-Brandenburg Aerospace Allianz e.V.
Berlin-Brandenburg Aerospace Allianz e.V. Miscellaneous Commercial ServicesCommercial Services Berlin-Brandenburg Aerospace Allianz e.V. provides aerospace support services. It specializes in connecting, networking and counseling, mediating political and industrial interests, representing members worldwide and, analyzing and administering aero-industrial projects. The company was founded in 1998 and is headquartered in Wildau, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Universität Stuttgart | College/University | Graduate Degree | |
NRW.Bank (Private Equity)
NRW.Bank (Private Equity) Investment ManagersFinance NRW.Bank (Private Equity) (NRWB PE) is the private equity operating division of the NRW Bank which traces their origins to 2002 when Westdeutsche Landesbank Girozentrale was split up into two entities. From this basis and further to the 2004 Reorganization Act, the current foundations for NRW Bank were established. Headquartered in Dusseldorf, Germany, NRWB PE specializes in providing capital and business development support for SMEs in North Rhine-Westphalia. They manage a number of private equity funds. Through mezzanine capital as a co-investor alongside lead investors, they provide equity limited to minority stakes as a silent partner. | Investment Managers | Private Equity Investor | |
Ruhr-Universität Bochum | College/University | Graduate Degree | |
Licentec
Licentec Miscellaneous Commercial ServicesCommercial Services Licentec provides evaluation of technology, patents, licensing, and IP management services. It offers support services to universities, knowledge institutions, companies, venture capitalists, and entrepreneurs in the commercialization of technology. The company was founded in 1978 and is headquartered in Bilthoven, the Netherlands | Miscellaneous Commercial Services | Director/Board Member | |
University of Duisburg-Essen | College/University | Doctorate Degree | |
Abalos Therapeutics GmbH
Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany. | Biotechnology | Director/Board Member | |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
BICO GROUP AB | Biotechnology | Director/Board Member | |
Fasciotens GmbH
Fasciotens GmbH Packaged SoftwareTechnology Services Fasciotens GmbH engages in the development of external medical device that provides solution for the open abdomen or abdominal compartment syndrome. It offers fasciotens abdomen. The company was founded by Gereon Lill and Frank Beyer in 2016 and is headquartered in Essen, Germany. | Packaged Software | Director/Board Member | |
Cryotherapeutics GmbH | Director/Board Member | ||
Technical University of Berlin | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 30 |
Paesi Bassi | 8 |
Svezia | 4 |
Francia | 3 |
Belgio | 2 |
Settori
Health Technology | 20 |
Consumer Services | 9 |
Finance | 7 |
Commercial Services | 7 |
Process Industries | 2 |
Posizioni
Director/Board Member | 31 |
Private Equity Investor | 6 |
Chairman | 5 |
Corporate Officer/Principal | 4 |
Doctorate Degree | 3 |
Contatti più connessi
Insiders | |
---|---|
Aristotelis Nastos | 17 |
Bart Bergstein | 12 |
Joachim Rautter | 11 |
Karlheinz Schmelig | 11 |
Nicole Faust | 4 |
Klaus Zimmermann | 1 |
Andrea Schilz | 1 |
- Borsa valori
- Insiders
- Pauline Rudd
- Connessioni Società